Passage Bio (NASDAQ:PASG) Announces Restructuring Plan and Financial Update

Passage Bio, Inc., disclosed in an 8-K filing on January 8, 2025, that it has initiated a restructuring plan aimed at ceasing lab operations at its leased laboratory space in Hopewell, New Jersey, spanning about 62,000 square feet. The Board of Directors of Passage Bio approved this plan to align its workforce with strategic research […]

Leave a Reply

Your email address will not be published.

Previous post Hilton Worldwide Holdings Inc. (NYSE:HLT) Given Average Rating of “Hold” by Brokerages
Next post ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024